Findings from Xiangya Medical College Update Understanding of Behcet Disease (Exploring the Pharmacological Mechanism of tripterygium Wilfordii Hook for Treatment of Behcet's Disease Using Network Pharmacology and Molecular Docking).

A study conducted by researchers at Xiangya Medical College in Hunan, China, aimed to explore the pharmacological mechanism of Tripterygium wilfordii hook (TWH) for the treatment of Behcet's disease (BD). The researchers used network pharmacology and molecular docking to investigate the bioactive constituents of TWH and their corresponding target genes, as well as the binding affinity between these constituents and the target genes. They identified 25 intersection genes related to both TWH and BD, as well as 27 bioactive ingredients of TWH. The study concluded that TWH has the potential to treat BD and provided a theoretical foundation for further research. [Extracted from the article]

Copyright of Drug Week is the property of NewsRx and its content may not be copied or emailed to multiple sites or posted to a listserv without the copyright holder's express written permission. However, users may print, download, or email articles for individual use. This abstract may be abridged. No warranty is given about the accuracy of the copy. Users should refer to the original published version of the material for the full abstract. (Copyright applies to all Abstracts.)